Amphastar Pharmaceuticals : Jefferies Global Healthcare Conference Presentation

Published: 2025-06-03 17:26:05 ET AMPH

Published on 06/03/2025 at 17:26

Injectables Inhalation Intranasal

Biosimilar Interchangeable

Jefferies Global Healthcare Conference

June 5th, 2025

Highly Purified Peptide/Protein

Proprietary

Complex Generic Combination Products

Company Overview

One-

Stop

Fully Integrated

Business Model, R&D, Manufacturing and Distribution

Dual

Strategies Growth Model

Pipeline Development

Strategic Acquisitions

Three-H

Focus

High Quality

High Efficiency

High Technology

Product Development

API / Key Components Manufacturing

US Based Finished Product Manufacturing

Marketing

Control over

quality and compliance throughout

the product development and manufacturing cycle

Distribution

5

Extensive in-house product development capabilities

Technical Platforms

State-of-the-art instruments

Animal studies

Clinical research team

Fully integrated back-end manufacturing capabilities

API and key materials

Device and key components

Complete front-end integration

Marketing

Distribution

Disclaimer

Amphastar Pharmaceuticals Inc. published this content on June 03, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 03, 2025 at 21:25 UTC.